Lori Rubin Garber
Partner
Based in Washington, D.C., Lori is a government enforcement defense lawyer, health care litigator, and False Claims Act attorney.聽 She is also a former chair of the firm鈥檚 national Government Enforcement Defense & Investigations practice group.
鈥淟ori is an excellent litigator 鈥 she is smart, knowledgeable and business-savvy.鈥 鈥淟ori is an excellent partner. She is easy to work with and provides practical advice.鈥
鈥 Chambers and Partners USA
Lori defends clients all over the country in government investigations and enforcement actions, conducts internal investigations particularly as related to allegations of fraud or other wrongdoing, and files and defends health care litigation. Her clients are typically health care industry participants, government contractors, and other recipients of government funding.
Health Care Litigation, Investigations, and Enforcement Defense
Lori brings significant health care experience to investigations and litigation, particularly in matters initiated by or otherwise adverse to the government and whistleblowers. Her health care sector clients have included hospitals, health systems, physician groups, pharmacies, medical laboratories, emergency medical services providers, pharmaceutical manufacturers, pharmaceutical care services companies, durable medical equipment suppliers, medical device manufacturers, grant recipients, digital health providers, private equity funds, skilled nursing facilities, management companies, and consulting firms.
The matters Lori handles frequently arise under the False Claims Act, the Anti-Kickback Statute, the physician self-referral prohibition (the Stark law), the Administrative Procedure Act, and various state law Consumer Protection Act statutes, and from whistleblower or company concerns about compliance or potential wrongdoing.
COVID-19 Fraud Litigation, Investigations, and Enforcement Defense
Lori鈥檚 considerable False Claims Act experience includes conducting investigations and responding to government inquiries regarding various COVID-19 relief programs. She has responded to Department of Justice Civil Investigative Demands on behalf of several entities related to loans issued through the Small Business Administration鈥檚 Paycheck Protection Program.
Government Contract Litigation, Investigations, and Enforcement Defense
Lori鈥檚 False Claims Act practice extends to government contractors. She has responded to multiple Civil Investigative Demands and subpoenas to government contractors in the last several years, including one in which she represented a global government contractor in a multiyear investigation by multiple federal agencies and achieved a government declination of the case pre-litigation. In addition, she has defended False Claims Act cases in litigation on behalf of government contractors.聽 She also has experience defending contractors in Anti-Terrorism Act litigation.
Investigations and Litigation About Data Security and Financial Improprieties
Lori conducts internal investigations, on behalf of companies and board committees, to investigate concerns of fraud, employee misconduct, data security, and billing irregularities, and she investigates and litigates a multitude of cases, particularly as related to allegations of wrongdoing.
Representative Experience
Health Care Enforcement Defense
- Defended a national durable medical equipment supplier against a multiyear U.S. Department of Justice (DOJ) investigation into allegations that the company violated the False Claims Act. Lori鈥檚 work included conducting an intensive internal investigation, coordinating the response to multiple Civil Investigative Demands and related, extensive negotiations with the government, and successfully resolving DOJ and whistleblower claims without her client having to step foot in a courtroom.
- Successfully defended a nonprofit medical center against allegations that it violated the False Claims Act, New York False Claims Act, Anti-Kickback Statute, and Stark Law. Won motion to dismiss in federal court, achieving dismissal of the case.
- Successfully defended a nonprofit medical center and a related pharmacy against allegations they violated the False Claims Act, Anti-Kickback Statute, and Stark Law. Won motion to dismiss in federal court, achieving dismissal with prejudice.
- Represented a national medical laboratory in federal court against allegations that the laboratory violated the False Claims Act, the California False Claims Act, the Anti-Kickback Statute, and the California Insurance Frauds Prevention Act. Lori鈥檚 work included leading the litigation against the whistleblower, including a partially successful motion to dismiss, and successfully resolving the matter with the whistleblowers and federal and state governments in mediation.
- Responded to multiple federal and state government subpoenas and inquiries related to the opioid crisis and successfully defended client in related investigations.
- Counseled clients on potential litigation regarding state laws in the post-Dobbs era.
Other Health Care Litigation
- Successfully challenged a Medicare rate reduction promulgated by the United States Department of Health & Human Services (HHS) in federal court, resulting in a remand to the agency and a related increase in payments to hospitals nationally.
- Successfully challenged HHS approval of a Medicaid state plan amendment in federal court, achieving vacatur of HHS鈥檚 approval.
- Successfully negotiated settlement agreements with HHS in multiple matters related to Medicare reimbursement, resulting in significant sums being paid to hospital and consulting firm clients.
- Intervened in federal court litigation on behalf of a pharmaceutical manufacturer when its competitor challenged Food & Drug Administration agency action and inaction impacting the client. Successfully reached resolution.
- Leads the Foley team that serves as lead counsel to, and regularly advises, a national hospital trade association on a variety of matters in the health care industry.
Government Contract Litigation, Investigations, and Enforcement Defense
- Represented a global government contractor in a multiyear investigation by multiple federal agencies and achieved a government declination of case pre-litigation.
- Defended a global government contractor in False Claims Act litigation in federal court against a whistleblower until a successful case resolution was reached.
Investigations and Litigation About Data Security and Financial Improprieties
- Conducted an internal investigation on behalf of a large multinational company related to misappropriation of company funds and potential misappropriation of sensitive business data.
- Conducted an internal investigation on behalf of a physician group related to competitor allegations of stolen business data.
- Conducted an internal investigation on behalf of energy company related to suspected improper financial transactions.
Awards and Recognition
- Named a D.C. Rising Star by The National Law Journal (August 2024)
- Chambers-ranked in the District of Columbia for Health Care in Chambers USA: America鈥檚 Leading Lawyers for Business (2024鈥损谤别蝉别苍迟)
- Named to DCA Live鈥檚 2023 Emerging Women Leaders in Private Practice list
- Selected for inclusion to the Washington D.C. Rising Stars list by聽Super Lawyers Magazine聽(2014鈥损谤别蝉别苍迟)
- Firm selected for inclusion in Lex Machina鈥檚 False Claims Act Litigation Report 2021 as a Top 10 Most Active Defendants鈥 Law Firms by Cases Filed from 2016 to 2020 (Oct. 2021)
Presentations and Publications
- Co-author, 鈥Supreme Court Clarifies Scope of Federal Fraud Statutes in Connection with False DBE Reporting on Federally Funded Projects,鈥 foley Viewpoints (May 29,2025)
- Co-author, 鈥DOJ Ramps Up Anti-DEI Enforcement,鈥 Foley Viewpoints (May 22, 2025)
- Co-author, 鈥DOJ Criminal Division Updates (Part 3): New Reasons for Companies to Self-Disclose Criminal Conduct,鈥 Health Care law Today (May 15, 2025)
- Co-author, 鈥DOJ Criminal Division Updates (Part 2): Department of Justice Updates its Corporate Criminal Whistleblower Awards Pilot Program,鈥 Health Care law Today (May 15, 2025)
- Co-author, 鈥DOJ Criminal Division Updates (Part 1): DOJ鈥檚 New White Collar Crime Enforcement Plan,鈥 Health Care law Today (May 15, 2025)
- Co-author, 鈥The Northern District of Illinois Endorses 鈥淏ut For鈥 Causation Standard for AKS-Premised False Claims Act Cases,鈥 Foley Viewpoints (May 5, 2025)
- Co-author, 鈥淔ederal Judge Restrains Liability for Alleged False DEI Certifications,鈥 Foley Viewpoints (April 2, 2025)
- Co-author: 鈥What Every Multinational Company (Doing Business in Mexico) Should Know About 鈥 Mitigating Risks From ATA Scrutiny in a New Enforcement Regime,鈥 Manufacturing Industry Advisor (March 6, 2025)
- Co-author, 鈥Anti-Kickback Statute Premised False Claims Cases: The 鈥楤ut For鈥 Causation Standard Finds Support from First Circuit,鈥 Foley Viewpoints (February 20, 2025)
- Co-author, 鈥Renewed Prohibition on Use of Sub-Regulatory Guidance 鈥 Key to False Claims Act Cases,鈥 Foley Viewpoints (February 17, 2025)
- Co-author, 鈥How Risky Are DEI Programs Under Trump 2.0?,鈥 Foley Viewpoints (January 28, 2025)
- Speaker, 鈥淲hat Does the End of Chevron Deference Mean for Health Care?,鈥 Association of Corporate Counsel Health Law Network (October 30, 2024)
- Speaker, 鈥淐CHP 2024 Webinar Series: Loper Bright/Chevron鈥 (August 28, 2024)
- Co-author, 鈥Chevron鈥檚 Demise Creates New False Claims Act Defenses,鈥 Health Law Today (July 16, 2024)
- Presenter, 鈥淔alse Claims Act Updates,鈥 Association of Corporate Counsel Health Law Network (March 5, 2024)
- Co-author, 鈥New False Claims Act Stats Show Jump in DOJ-Driven Investigations,鈥 Health Care Law Today (February 23, 2024)
- Co-author, 鈥What Every Multinational Company Should Know About . . . The False Claims Act,鈥 Manufacturing Industry Advisor (February 7, 2024)
- Author, 鈥Health-Care Fraud Scrutiny Heats Up For Companies, Providers,鈥 Bloomberg Law (January 2, 2024)
- Moderator, 鈥淲e Can Handle the Truth: Let鈥檚 Meet the United States Health Law Enforcers,鈥 Association of Corporate Counsel Annual Meeting (Oct. 25, 2023)
- Quoted, 鈥淪upreme Court Decision Could Make It Easier to Dismiss Frivolous Whistleblower Claims,鈥 Compliance & Policy Report, Vol. 1, No. 7 (September 2023)
- Author, 鈥False Claims Act Supreme Court News: Government Dismissal Authority 鈥淣ot a Close Call;鈥 Constitutionality of Qui Tam Provisions May Be Closer Call,鈥 Foley Insights (June 20, 2023)
- Author, 鈥Supreme Court Overturns FCA Scienter Cases,鈥 Foley Insights (June 1, 2023)
- Author, 鈥Growing Scrutiny of Private Equity in Health Care,鈥 Foley鈥檚 Health Care Law Today (March 29, 2023)
- Author, 鈥Supreme Court Changes Its Mind, Decides Not To Mire into Attorney Client Privilege,鈥 Foley Insights (January 24, 2023)
- Author, 鈥Supreme Court Considers Extent to which Business Communications Are Protected By the Attorney Client Privilege,鈥 Foley Insights (January 12, 2023)
- Author, 鈥Court Calls Underlying Legal Standards 鈥淣o Model of Clarity鈥 but Allows False Claims Act Case To Proceed Anyway,鈥 Foley鈥檚 Health Care Law Today (Jan. 11, 2023)
- Author, 鈥FCA Managed Care Case Update: A Court鈥檚 View of ICD Guidelines in Risk Adjustment Cases,鈥 Foley鈥檚 Health Care Law Today (Dec. 27, 2022)
- Author, 鈥False Claims Act: Prediction on Supreme Court Ruling on Government Dismissal Authority,鈥 Foley鈥檚 Health Care Law Today (Dec. 15, 2022)
- Author, 鈥,鈥 Association of Corporate Counsel (Dec. 6, 2022)
- Author, 鈥,鈥 National Law Review (Sep. 21, 2022)
- Panelist, 鈥淗ow Do Healthcare Innovations Lead to New Enforcement Risks?,鈥 Physician Legal Issues: Healthcare Delivery & Innovation Conference, American Bar Association (Sep. 15, 2022)
- Panelist, 鈥淐OVID-Related Enforcement Activity,鈥 ACC Online Education, Association of Corporate Counsel (Sep. 7, 2022)
- Panelist, 鈥淐urrent Legal Risks for Government Contractors,鈥 FORVIS Issues in Focus Webinar (June 7, 2022)
- Author, 鈥California Appellate Court Holds Plaintiffs in Website Accessibility Challenges Must Have “Bona Fide Intent” To Use Services,鈥 番茄社区; Lardner LLP Insights (October 8, 2021)
- Author, 鈥Rising Importance of Sub-Regulatory Guidance in False Claims Act Cases,鈥 Foley’s Health Care Law Today (August 26, 2021)
- Author, 鈥Hidden Implications of Current Trends in Enforcement,鈥 Healthcare Business Today (August 20, 2021)
- Author, 鈥A Target on Telehealth: Government Action Against Telehealth Fraud in the Wake of COVID-19,鈥 American Health Law Association (July 14, 2021)
- Author, 鈥淭he Risks of ‘Swapping’ for Durable Medical Equipment,鈥 McKnight鈥檚 Long-Term Care News (April 14, 2021)
- Author, 鈥Anti-Fraud Enforcement in the Coronavirus Era,鈥 Foley’s Coronavirus Resource Center (March 23, 2020)
Key Health Care Enforcement Trends Under the Trump Administration: FCA, Data Analytics, and Emerging Risk Areas
False Claims Act Enforcement in 2026
False Claims Act Enforcement in 2026
DOJ Creates New National Fraud Division
Foley Secures Top Rankings in Chambers USA 2025